Contact Supplier

Contact Supplier

To get in touch with Evercyte GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .
    New study confirms effectiveness of unique Evercyte CD81 antigen recognition technology

    Evercyte GmbH News Releases

    Find the latest News from Evercyte GmbH

    Page 1 of 3
    New study confirms effectiveness of unique Evercyte CD81 antigen recognition technology
    New study confirms effectiveness of unique Evercyte CD81 antigen recognition technology Learn More >
    MDimune and Evercyte form partnership for developing tumor-targeting EVs
    MDimune and Evercyte form partnership for developing tumor-targeting EVs Learn More >
    Evercyte bringing EV toolbox insights to GSEV/ASEV Autumn Meeting
    Evercyte bringing EV toolbox insights to GSEV/ASEV Autumn Meeting Learn More >
    Evercyte bringing latest cell-based advances to BIO-Europe Hamburg
    Evercyte bringing latest cell-based advances to BIO-Europe Hamburg Learn More >
    Evercyte promotes human telomerized cells for preclinical testings and oduction of exosomes at BioJapan in Yokohama
    Evercyte promotes human telomerized cells for preclinical testings and oduction of exosomes at BioJapan in Yokohama Learn More >
    Evercyte brings new EV research focus to BIO 2019 Philadelphia
    Evercyte brings new EV research focus to BIO 2019 Philadelphia Learn More >
    Evercyte brings new EV research focus to ESACT Copenhagen
    Evercyte brings new EV research focus to ESACT Copenhagen Learn More >
    Evercyte brings new extracellular vesicle research focus to ISEV Kyoto
    Evercyte brings new extracellular vesicle research focus to ISEV Kyoto Learn More >
    Evercyte and Boehringer Ingelheim to investigate EVs for NextGen therapies
    Evercyte and Boehringer Ingelheim to investigate EVs for NextGen therapies Learn More >
    Evercyte brings new human cell line development solutions to 3Rs Days
    Evercyte brings new human cell line development solutions to 3Rs Days Learn More >
    Evercyte hosting Altertox Training Workshop on GCCP in Toxicology
    Evercyte hosting Altertox Training Workshop on GCCP in Toxicology Learn More >
    Evercyte brings new human cell line development solutions to in-vitro toxicology at ESTIV Berlin
    Evercyte brings new human cell line development solutions to in-vitro toxicology at ESTIV Berlin Learn More >
    Page 1 of 3